Virbac has launched Canixin L, a new L2 Leptospirosis vaccine for dogs.

Canixin L is an inactivated bacterial vaccine used to stimulate active immunity in dogs against two serogroups of Leptospira interrogans: Canicola and Icterohaemorrhagiae.

The new vaccine is licensed to reduce infection, clinical signs, kidney colonisation, renal lesions and shedding in the urine.

Virbac says Canixin L will play a crucial role in minimising the risk of the disease in both the individual and other animals that may come into contact.

It is licensed for use in dogs from 8 weeks of age, with a second injection administered 3 to 4 weeks later.

Virbac says that for the Canicola serogroup, Canixin L offers the highest level of protection, including prevention of mortality.

Rain Beckles – Product Manager, said: “Virbac is pleased to be able to offer Canixin L, allowing those using Canixin DHPPi/L to vaccinate with L2 only in the intermediate years.

“It also provides an excellent opportunity for practices with clients specifically requesting an L2 vaccine.”

https://uk.virbac.com 

PS: Whilst you're here, take a moment to see our latest job opportunities for vet nurses.